Dr. Céline Gounder, an internist, epidemiologist and infectious disease specialist, is a CBS News medical contributor as well as senior fellow and editor-at-large for public health at KFF Health News.

The U.S. Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday. The ...

But there's news on that front — a new medication, elinzanetant, sold under the name Lynkuet. It's a once-a-day pill designed to treat moderate to severe "hot flashes," also called vasomotor symptoms.

The U.S. Food and Drug Administration has approved Lynkuet, a new daily pill from Bayer that provides a non-hormonal option for treating hot flashes, common during menopause. The drug, known ...

Menopause after breast cancer can cause symptoms that substantially impact quality of life, making individualized, multidisciplinary care and shared decision-making critical, experts noted during ...

The U.S. Food and Drug Administration will remove the “black box” warning labels on many hormone therapy drugs used for menopause and perimenopause symptoms — a major turnaround that’s likely to ...

WASHINGTON (AP) — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the ...

The U.S. Food and Drug Administration has approved Lynkuet, a new daily pill from Bayer that provides a non-hormonal option for treating hot flashes. The drug, known generically as elinzanetant, is ...